|Articles|February 25, 2022
News Roundup: February 21 to February 25
Author(s)Lauren Biscaldi, MS
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Drug Delivery: The Sky is Not the Limit
The use of drones to deliver critically important therapies can help overcome the barriers to care that impact patients in metropolitan areas.
AbbVie Submits Supplemental NDA for Vraylar for Adjunctive MDD Therapy
Cariprazine is already approved to treat schizophrenia and bipolar I in adults.
This Week in COVID-19: As New Omicron Variant Circulates, States Lift Mask Mandates
COVID-19 updates and news to know as of February 21, 2022.
Cancer and COVID-19: Solving the Puzzle of Vaccination
Recent treatment may affect the antibody response, particularly among those with hematologic cancers.
Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference Product
Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
2
FDA Approves First 1-Minute Self Test for HIV
3
CVS Pharmacy Acquires Select Rite Aid Assets in 3 States, Accounting for Over 600 Stores
4
Vaccine Hesitancy Rises, Highlighting a Crucial Role for Pharmacists
5
